Mkt Cap$2.29T-1.02%
24h Vol$87.18B
BTC Dom56.0%
ETH Dom9.2%
F&G15Extreme Fear
BTC$63,875.00-1.14% ETH$1,740.21-1.36% USDT$0.9991+0.00% BNB$588.67-2.27% USDC$0.9997-0.01% XRP$1.16-2.13% SOL$70.83-1.52% TRX$0.32+0.13% FIGR_HELOC$1.02-1.42% HYPE$71.38+0.58% DOGE$0.0844-1.32% USDS$0.9997+0.00% RAIN$0.0145+3.62% LEO$9.63+0.68% XLM$0.2356+6.99% ZEC$468.23-5.77% BTC$63,875.00-1.14% ETH$1,740.21-1.36% USDT$0.9991+0.00% BNB$588.67-2.27% USDC$0.9997-0.01% XRP$1.16-2.13% SOL$70.83-1.52% TRX$0.32+0.13% FIGR_HELOC$1.02-1.42% HYPE$71.38+0.58% DOGE$0.0844-1.32% USDS$0.9997+0.00% RAIN$0.0145+3.62% LEO$9.63+0.68% XLM$0.2356+6.99% ZEC$468.23-5.77%
News

ANIP

Total Stories
1
Section
ANIP
ANI Pharmaceuticals Surpasses Expectations with $131.7 Million in Q4 Net Revenues
Earnings

ANI Pharmaceuticals Beats Expectations with $137.4 Million in Q1 Revenues

ANI Pharmaceuticals, Inc. has achieved remarkable financial success in Q1, with record-breaking net revenues of $137.4 million.

Tim FriesMay 10, 20243 min read